Valuation

Huawei's Jason Ding named as the world's top IP dealmaker

The head of the IP group at the Chinese telecoms giant is the first Asia-based leader to top our annual Market Makers list of the most influential patent value creators on the planet

Huawei's Jason Ding named as the world's top IP dealmaker
24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market.

24 Sep 2018

Inside Apple’s negotiations with a Chinese patent owner on the war path

The smartphone giant faces an infringement claim in Shanghai over Siri-related technology. Communications published by Chinese inventor show how the conflict developed.

Latest

View all
21 Sep 2018

The world's top IP dealmakers and value creators identified – part two

We reveal who is listed in positions 30 to 21 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

20 Sep 2018

Revealed: the leaders of the global IP market - part one

We begin the countdown of this year’s IAM Market Makers list, which names the elite individuals who drive global patent dealmaking and value creation from their positions inside corporates, NPEs, investment institutions and other entities. Today, positions 40 to 31. Read more

4 Sep 2018

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Despite forecasts of a sharp rise in pharma deal-making activity, it has proved to be a slow year on the M&A front. One reason may be that licensing partnerships are proving far more popular than many had expected. Read more

6 Aug 2018

Indian ministry said to propose re-introduction of outbound royalty caps

Proposed limits on royalty payments would be even stricter than those scrapped in 2009 liberalisation of FDI policies. Impact would be felt by global brand and technology giants with listed subsidiaries in India. Read more

News

View all
7 Jun 2018

Intellectual Ventures, Amex veterans to launch blockchain-powered IP trading platform

New start-up Operem hopes to launch IP exchange by year's end after closing series A funding round in April. CEO Tim Londergan says the project can lure financial investors into the IP world.  Read more

25 May 2018

Our auto royalty rates won't change no matter how many patent owners join us, Avanci confirms

There will be no changes to the $3 to $15 per car royalty fees licensees are asked to pay to access the patents that form the Avanci auto patent platform, the firm has told IAM.  “As we add new patent owners to the Avanci platform, the price the… Read more

22 May 2018

Chinese company which raised $1.3 billion in IP-backed financing has Virginia factory site foreclosed

It would appear that the recipient of the largest ever IP-backed loan has come full circle to cautionary tale. Tranlin Paper, based in China’s Shandong Province, borrowed well over a billion dollars from the China Development bank in 2014 on the… Read more

7 May 2018

CRISPR dust-up; compulsory licensing in China; Novartis CEO wants US reform, and more - April's Life Sciences IP Round-up

In this month’s round-up of life sciences-related patent news, we report on the year’s first pharma mega-merger, the latest developments in a must-watch CRISPR-Cas9 patent dispute, calls from Novartis’ CEO for reform to the US biosimilar patent… Read more

Analysis

View all
27 Jul 2018

Revolutionary change in CRISPR patent landscape poses tough questions for life sciences companies

The patent landscape for gene editing technology could be unrecognisable in just a few years, as grants grow exponentially and commercial applications accelerate.  Read more

16 Jul 2018

Ericsson appeal brief sets stage for next chapter in epic SEP FRAND dispute with TCL

Ericsson has put together the CAFC brief for its appeal against the Central District of California federal court’s decision in its litigation with Chinese handset manufacturer TCL. Read more

9 Jul 2018

Pharma innovators will welcome SCOTUS decision to tackle 102 uncertainty; but must wait for 101 guidance

The US Supreme Court’s treatment of patentability in recent times has often been frustrating to life sciences innovators, with last month’s refusal to grasp the nettle of patent eligible subject matter in Cleveland Clinic Foundation v True Health… Read more

21 Jun 2018

NPE takes aim at Twitter in notable test for former Yahoo! patents

Twitter found itself on the wrong end of an infringement lawsuit late last month when an entity called Digi Portal accused the social media company of infringing on one of its patents.  According to a recent RPX newsletter, Digi Portal is an… Read more

Insights

View all
1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past … Read more

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

1 Aug 2016

Brexit leaves the UPC in limbo – and that’s no bad thing

The UK vote to leave the European Union may have surprised and disappointed many in the IP community, but a rush to bypass the decision and implement the unitary patent package would be a mistake Read more

Find an expert

J Jeffrey Gunn
Director
Salt Lake City UT, United States
TraskBritt PC